HR
HOOK

Howe & Rusling’s HOOKIPA Pharma HOOK Stock Holding History

Howe & Rusling’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20
Closed – – 1117
2022
Q2 		$0 Buy
+20
New +$331 ﹤0.01% 1104

Other funds holding HOOK

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Howe & Rusling's HOOK Position: Q3 2022 in Review

Howe & Rusling sold out of HOOKIPA Pharma (HOOK) in Q3 2022, closing a stake of 20 shares.

Howe & Rusling first reported a position in HOOK in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 54 funds tracked by Wall St. Rank hold HOOK as of Q3 2022.

  • Howe & Rusling reported no remaining HOOKIPA Pharma position as of Q3 2022 after selling out during the quarter.
  • Howe & Rusling sold 20 HOOKIPA Pharma shares in Q3 2022.
  • Howe & Rusling first reported a position in HOOKIPA Pharma in Q2 2022 and held it in 1 quarter.
  • Howe & Rusling's HOOKIPA Pharma position peaked at $0 in Q2 2022.
  • 54 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2022.

Based on Howe & Rusling's 13F filing for Q3 2022, filed 14 Nov 2022.